Nevertheless, the underlying mechanism responsible for the altered expression of both miR-203 and miR-200c and ABCB1 in doxorubicin resistance breast cancer and their specific role and mechanism of modulation of the activity of the ABCB1 efflux pump in drug resistance, still need to be elucidated. This evidence concerns the gene ABCB1 and breast cancer.